The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Relative risk of hepatotoxicity associated with cyclin-dependent kinase inhibitors (CDK4/6i): A systematic review and meta-analysis of phase 3 randomized controlled trials.
 
Nusrat Jahan
Stock and Other Ownership Interests - Merck
 
Sariya Wongsaengsak
No Relationships to Disclose
 
Shabnam Rehman
Consulting or Advisory Role - Amgen; AstraZeneca
 
Nimesh Adhikari
No Relationships to Disclose
 
Lukman Aderoju Tijani
Honoraria - AstraZeneca
 
Arrvind Raghunath
No Relationships to Disclose